Literature DB >> 21263069

Activation receptor-induced tolerance of mature NK cells in vivo requires signaling through the receptor and is reversible.

Fred D Bolanos1, Sandeep K Tripathy.   

Abstract

NK cell responses are determined by signals received through activating and inhibitory cell surface receptors. Ly49H is an NK cell-specific activating receptor that accounts for the genetic resistance to murine CMV (MCMV). The Ly49H receptor has been shown to interact with two adaptor proteins (DAP12 and DAP10). In the context of MCMV infection, interaction of m157 (the MCMV-encoded ligand for Ly49H) with Ly49H results in activation of Ly49H-expressing NK cells. Chronic exposure of Ly49H with m157, however, induces tolerance in these same cells. The mechanism of this tolerance remains poorly understood. Using a transgenic mouse model, we demonstrate that induction of tolerance in Ly49H(+) NK cells by chronic exposure to m157, in vivo, requires signaling through the Ly49H adaptor protein DAP12, but not the DAP10 adaptor protein. Furthermore, mature Ly49H-expressing NK cells from wild-type mice can acquire a tolerant phenotype by 24 h posttransfer into a transgenic C57BL/6 mouse that expresses m157. The tolerant phenotype can be reversed, in vivo, if tolerant NK cells are transferred to mice that do not express the m157 protein. Thus, continuous activating receptor engagement can induce a transient tolerance in mature NK cells in vivo. These observations provide new insight into how activating receptor engagement shapes NK cell function and has important implications in how NK cells respond to tumors and during chronic viral infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263069      PMCID: PMC3256587          DOI: 10.4049/jimmunol.1003046

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.

Authors:  David E Oppenheim; Scott J Roberts; Sarah L Clarke; Renata Filler; Julie M Lewis; Robert E Tigelaar; Michael Girardi; Adrian C Hayday
Journal:  Nat Immunol       Date:  2005-08-14       Impact factor: 25.606

2.  Licensing of natural killer cells by host major histocompatibility complex class I molecules.

Authors:  Sungjin Kim; Jennifer Poursine-Laurent; Steven M Truscott; Lonnie Lybarger; Yun-Jeong Song; Liping Yang; Anthony R French; John B Sunwoo; Suzanne Lemieux; Ted H Hansen; Wayne M Yokoyama
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

Review 3.  MIC and other NKG2D ligands: from none to too many.

Authors:  Seiamak Bahram; Hidetoshi Inoko; Takashi Shiina; Mirjana Radosavljevic
Journal:  Curr Opin Immunol       Date:  2005-10       Impact factor: 7.486

4.  Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.

Authors:  Katrin Wiemann; Hans-Willi Mittrücker; Ute Feger; Stefan A Welte; Wayne M Yokoyama; Thomas Spies; Hans-Georg Rammensee; Alexander Steinle
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

5.  Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I.

Authors:  Sandeep K Tripathy; Hamish R C Smith; Erika A Holroyd; Jeanette T Pingel; Wayne M Yokoyama
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.

Authors:  Roi Gazit; Raizy Gruda; Moran Elboim; Tal I Arnon; Gil Katz; Hagit Achdout; Jacob Hanna; Udi Qimron; Guy Landau; Evgenia Greenbaum; Zichria Zakay-Rones; Angel Porgador; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2006-03-26       Impact factor: 25.606

7.  Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells.

Authors:  Jérôme D Coudert; Jacques Zimmer; Elena Tomasello; Marek Cebecauer; Marco Colonna; Eric Vivier; Werner Held
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

8.  NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.

Authors:  Susan Gilfillan; Emily L Ho; Marina Cella; Wayne M Yokoyama; Marco Colonna
Journal:  Nat Immunol       Date:  2002-11-11       Impact factor: 25.606

9.  NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors.

Authors:  Béatrice Le Maux Chansac; Alessandro Moretta; Isabelle Vergnon; Paule Opolon; Yann Lécluse; Dominique Grunenwald; Marek Kubin; Jean-Charles Soria; Salem Chouaib; Fathia Mami-Chouaib
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

10.  The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44).

Authors:  Andrea De Maria; Manuela Fogli; Paola Costa; Giuseppe Murdaca; Francesco Puppo; Domenico Mavilio; Alessandro Moretta; Lorenzo Moretta
Journal:  Eur J Immunol       Date:  2003-09       Impact factor: 5.532

View more
  12 in total

1.  Activation Receptor-Dependent IFN-γ Production by NK Cells Is Controlled by Transcription, Translation, and the Proteasome.

Authors:  Sytse J Piersma; Melissa A Pak-Wittel; Andrea Lin; Beatrice Plougastel-Douglas; Wayne M Yokoyama
Journal:  J Immunol       Date:  2019-08-23       Impact factor: 5.422

2.  Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.

Authors:  Cathrine A Miner; Tusar K Giri; Claire E Meyer; Mark Shabsovich; Sandeep K Tripathy
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

3.  Prenatal Allospecific NK Cell Tolerance Hinges on Instructive Allorecognition through the Activating Receptor during Development.

Authors:  Amir M Alhajjat; Beverly S Strong; Amanda E Lee; Lucas E Turner; Ram K Wadhwani; John R Ortaldo; Jonathan W Heusel; Aimen F Shaaban
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

4.  Viral infection transiently reverses activation receptor-mediated NK cell hyporesponsiveness in an MHC class I-independent mechanism.

Authors:  Budhaditya Mazumdar; Fred D Bolanos; Sandeep K Tripathy
Journal:  Eur J Immunol       Date:  2013-04-09       Impact factor: 5.532

Review 5.  Unifying concepts of MHC-dependent natural killer cell education.

Authors:  Julie M Elliott; Wayne M Yokoyama
Journal:  Trends Immunol       Date:  2011-07-13       Impact factor: 16.687

Review 6.  Activating killer cell Ig-like receptors in health and disease.

Authors:  Martin A Ivarsson; Jakob Michaëlsson; Cyril Fauriat
Journal:  Front Immunol       Date:  2014-04-22       Impact factor: 7.561

Review 7.  The role of NK cells in HIV-1 protection: autologous, allogeneic or both?

Authors:  Jef Hens; Wim Jennes; Luc Kestens
Journal:  AIDS Res Ther       Date:  2016-03-18       Impact factor: 2.250

8.  Expression of the inhibitory receptor NKG2A correlates with increased liver and splenic NK cell response to activating receptor engagement.

Authors:  Claire E Meyer; Phillip N Key; Toby Zhu; Mark Shabsovich; Ann Ni; Sandeep K Tripathy
Journal:  Immun Inflamm Dis       Date:  2017-03-24

9.  Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation.

Authors:  Leah Schmidt; Banu Eskiocak; Ryan Kohn; Celeste Dang; Nikhil S Joshi; Michel DuPage; Da-Yae Lee; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-13       Impact factor: 11.205

10.  Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?

Authors:  Mario U Mondelli; Barbara Oliviero; Dalila Mele; Stefania Mantovani; Chiara Gazzabin; Stefania Varchetta
Journal:  Front Immunol       Date:  2012-11-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.